41 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Gainers

• ObsEva, Inc. OBSV stock increased by 24.8% to $4.03 during Tuesday's pre-market session. The market cap seems to be at $337.6 million. The most recent rating by H.C. Wainwright, on December 02, is at Buy, with a price target of $36.00.
• ContraFect, Inc. CFRX shares increased by 24.7% to $0.36. The market cap seems to be at $25.8 million.
• Aevi Genomic Medicine, Inc. GNMX shares increased by 8.1% to $0.15. The market cap seems to be at $8.1 million.
• Ritter Pharmaceuticals, Inc. RTTR shares moved upwards by 7.5% to $0.23. The market cap stands at $2.5 million.
• Xenetic Biosciences, Inc. XBIO shares increased by 6.9% to $1.40. The market cap stands at $6.8 million.
• Precision BioSciences, Inc. DTIL shares moved upwards by 5.6% to $10.03. The market value of their outstanding shares is at $328.7 million.
• Biocept, Inc. BIOC shares increased by 4.8% to $0.28. The market value of their outstanding shares is at $16.4 million.
• Clovis Oncology, Inc. CLVS stock rose 4.4% to $11.18. The market value of their outstanding shares is at $173.7 million. The most recent rating by Evercore ISI Group, on November 19, is at In-Line, with a price target of $8.00.
• Sanofi, Inc. SNY shares surged 4.2% to $47.20. The market cap seems to be at $115.4 billion. According to the most recent rating by Barclays, on December 06, the current rating is at Underweight.
• Enochian BioSciences, Inc. ENOB stock moved upwards by 3.2% to $6.50. The market cap stands at $263.7 million.
• Trevena, Inc. TRVN stock moved upwards by 2.7% to $0.73. The market cap stands at $88.8 million.
• Aurinia Pharmaceuticals, Inc. AUPH shares moved upwards by 2.7% to $16.20. The market cap stands at $456.3 million.
• Agilent Technologies, Inc. A stock increased by 2.3% to $83.50. The market cap stands at $23.4 billion. The most recent rating by UBS, on November 26, is at Neutral, with a price target of $87.00.
• Sierra Oncology, Inc. SRRA stock rose 2.2% to $0.45. The market cap seems to be at $23.1 million. The most recent rating by Oppenheimer, on December 06, is at Outperform, with a price target of $1.20.
• Intra-Cellular Therapies, Inc. ITCI shares increased by 2.2% to $11.80. The market value of their outstanding shares is at $511.0 million.
• Sorrento Therapeutics, Inc. SRNE stock rose 2.1% to $3.89. The market cap seems to be at $215.6 million. The most recent rating by JMP Securities, on October 07, is at Market Outperform, with a price target of $21.00.
• Advaxis, Inc. ADXS stock moved upwards by 1.8% to $0.83. The market cap seems to be at $7.8 million.
• Aptose Biosciences, Inc. APTO shares surged 1.7% to $3.60. The market cap seems to be at $113.9 million.
• Tandem Diabetes Care, Inc. TNDM shares increased by 1.4% to $59.55. The market cap stands at $3.6 billion. The most recent rating by Baird, on November 05, is at Outperform, with a price target of $71.00.
• Sage Therapeutics, Inc. SAGE stock rose 1.3% to $63.50. The market cap stands at $7.0 billion. According to the most recent rating by SVB Leerink, on December 06, the current rating is at Market Perform.
• Ocugen, Inc. OCGN shares moved upwards by 1.0% to $0.39. The market cap stands at $19.7 million. The most recent rating by Chardan Capital, on November 27, is at Buy, with a price target of $2.00.

Losers

• SCYNEXIS, Inc. SCYX shares plummeted 22.8% to $0.74 during Tuesday's pre-market session. The market value of their outstanding shares is at $67.1 million.
• Beyond Air, Inc. XAIR stock decreased by 9.3% to $3.69. The market cap seems to be at $46.1 million.
• Achieve Life Sciences, Inc. ACHV stock fell 4.8% to $0.99. The market cap seems to be at $10.4 million.
• Abeona Therapeutics, Inc. ABEO stock plummeted 4.8% to $2.80. The market cap seems to be at $120.9 million.
• Cassava Sciences, Inc. SAVA stock decreased by 3.0% to $1.62. The market cap stands at $20.6 million.
• Aurora Cannabis, Inc. ACB shares decreased by 2.5% to $2.55. The market cap seems to be at $3.6 billion. The most recent rating by Piper Jaffray, on October 22, is at Neutral, with a price target of $4.00.
• Onconova Therapeutics, Inc. ONTX shares decreased by 2.2% to $0.33. The market value of their outstanding shares is at $4.3 million.
• Seelos Therapeutics, Inc. SEEL stock fell 2.1% to $1.37. The market value of their outstanding shares is at $24.2 million.
• Forty Seven, Inc. FTSV stock declined 2.1% to $29.80. The market cap stands at $292.0 million. The most recent rating by Mizuho, on December 10, is at Buy, with a price target of $37.00.
• Galapagos, Inc. GLPG shares declined 1.8% to $211.95. The market cap stands at $11.3 billion. The most recent rating by Bank of America, on December 02, is at Neutral, with a price target of $199.00.
• Proteostasis Therapeutics, Inc. PTI stock fell 1.7% to $3.47. The market cap stands at $42.4 million.
• Aphria, Inc. APHA stock decreased by 1.6% to $5.01. The market value of their outstanding shares is at $1.2 billion.
• Titan Pharmaceuticals, Inc. TTNP stock decreased by 1.4% to $0.21. The market value of their outstanding shares is at $10.3 million. The most recent rating by Maxim Group, on October 23, is at Buy, with a price target of $1.00.
• Canopy Growth, Inc. CGC shares decreased by 1.2% to $21.01. The market cap stands at $6.9 billion. According to the most recent rating by Bank of America, on November 20, the current rating is at Buy.
• Cronos Group, Inc. CRON stock declined 1.1% to $6.88. The market value of their outstanding shares is at $2.3 billion. The most recent rating by Bank of America, on November 13, is at Buy, with a price target of $15.00.
• AstraZeneca, Inc. AZN shares plummeted 1.1% to $47.20. The market cap seems to be at $126.9 billion. The most recent rating by Cowen & Co., on December 02, is at Outperform, with a price target of $55.00.
• Teva Pharmaceutical Indus, Inc. TEVA shares plummeted 1.1% to $9.71. The market cap seems to be at $11.3 billion. According to the most recent rating by JP Morgan, on November 12, the current rating is at Neutral.
• Qiagen, Inc. QGEN shares fell 1.1% to $41.08. The market cap seems to be at $6.7 billion. The most recent rating by Commerzbank, on November 18, is at Buy, with a price target of $48.00.
• Tonix Pharmaceuticals, Inc. TNXP shares plummeted 1.0% to $0.96. The market cap stands at $4.6 million.
• InMode, Inc. INMD shares decreased by 1.0% to $42.27. The market cap stands at $983.5 million.